rs146381591

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2

The NM_000027.4(AGA):​c.436T>G​(p.Leu146Val) variant causes a missense change. The variant allele was found at a frequency of 0.000846 in 1,610,472 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0018 ( 1 hom., cov: 33)
Exomes 𝑓: 0.00075 ( 3 hom. )

Consequence

AGA
NM_000027.4 missense

Scores

5
9
5

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:9B:2

Conservation

PhyloP100: 4.05

Publications

9 publications found
Variant links:
Genes affected
AGA (HGNC:318): (aspartylglucosaminidase) This gene encodes a member of the N-terminal nucleophile (Ntn) hydrolase family of proteins. The encoded preproprotein is proteolytically processed to generate alpha and beta chains that comprise the mature enzyme. This enzyme is involved in the catabolism of N-linked oligosaccharides of glycoproteins. It cleaves asparagine from N-acetylglucosamines as one of the final steps in the lysosomal breakdown of glycoproteins. Mutations in this gene are associated with the lysosomal storage disease aspartylglycosaminuria that results in progressive neurodegeneration. Alternative splicing results in multiple transcript variants, at least one of which encodes an isoform that is subject to proteolytic processing. [provided by RefSeq, Nov 2015]
AGA Gene-Disease associations (from GenCC):
  • aspartylglucosaminuria
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, G2P, Orphanet, Myriad Women’s Health, Labcorp Genetics (formerly Invitae), Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.020604104).
BP6
Variant 4-177438816-A-C is Benign according to our data. Variant chr4-177438816-A-C is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 427059.
BS2
High Homozygotes in GnomAdExome4 at 3 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
AGANM_000027.4 linkc.436T>G p.Leu146Val missense_variant Exon 4 of 9 ENST00000264595.7 NP_000018.2 P20933
AGANM_001171988.2 linkc.436T>G p.Leu146Val missense_variant Exon 4 of 9 NP_001165459.1 P20933
AGAXM_047449722.1 linkc.436T>G p.Leu146Val missense_variant Exon 4 of 7 XP_047305678.1
AGANR_033655.2 linkn.498T>G non_coding_transcript_exon_variant Exon 4 of 8

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
AGAENST00000264595.7 linkc.436T>G p.Leu146Val missense_variant Exon 4 of 9 1 NM_000027.4 ENSP00000264595.2 P20933

Frequencies

GnomAD3 genomes
AF:
0.00180
AC:
274
AN:
152216
Hom.:
1
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00371
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00229
Gnomad ASJ
AF:
0.00115
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00187
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.000926
Gnomad OTH
AF:
0.00382
GnomAD2 exomes
AF:
0.00101
AC:
254
AN:
251396
AF XY:
0.00110
show subpopulations
Gnomad AFR exome
AF:
0.00400
Gnomad AMR exome
AF:
0.00162
Gnomad ASJ exome
AF:
0.000794
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0000924
Gnomad NFE exome
AF:
0.000774
Gnomad OTH exome
AF:
0.00163
GnomAD4 exome
AF:
0.000748
AC:
1090
AN:
1458138
Hom.:
3
Cov.:
33
AF XY:
0.000745
AC XY:
541
AN XY:
725698
show subpopulations
African (AFR)
AF:
0.00422
AC:
141
AN:
33426
American (AMR)
AF:
0.00163
AC:
73
AN:
44712
Ashkenazi Jewish (ASJ)
AF:
0.000958
AC:
25
AN:
26106
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39684
South Asian (SAS)
AF:
0.00113
AC:
97
AN:
86166
European-Finnish (FIN)
AF:
0.0000749
AC:
4
AN:
53412
Middle Eastern (MID)
AF:
0.00469
AC:
27
AN:
5758
European-Non Finnish (NFE)
AF:
0.000577
AC:
640
AN:
1108592
Other (OTH)
AF:
0.00136
AC:
82
AN:
60282
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.460
Heterozygous variant carriers
0
53
107
160
214
267
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
26
52
78
104
130
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00179
AC:
273
AN:
152334
Hom.:
1
Cov.:
33
AF XY:
0.00173
AC XY:
129
AN XY:
74492
show subpopulations
African (AFR)
AF:
0.00370
AC:
154
AN:
41580
American (AMR)
AF:
0.00229
AC:
35
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.00115
AC:
4
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5186
South Asian (SAS)
AF:
0.00187
AC:
9
AN:
4820
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10622
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.000911
AC:
62
AN:
68038
Other (OTH)
AF:
0.00378
AC:
8
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
15
30
46
61
76
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000940
Hom.:
0
Bravo
AF:
0.00234
TwinsUK
AF:
0.000270
AC:
1
ALSPAC
AF:
0.000519
AC:
2
ESP6500AA
AF:
0.00522
AC:
23
ESP6500EA
AF:
0.00151
AC:
13
ExAC
AF:
0.000931
AC:
113
EpiCase
AF:
0.00142
EpiControl
AF:
0.00136

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:9Benign:2
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Aspartylglucosaminuria Uncertain:5Benign:1
Sep 21, 2017
Mayo Clinic Laboratories, Mayo Clinic
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 27, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. -

Apr 27, 2019
Genomic Research Center, Shahid Beheshti University of Medical Sciences
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Dec 16, 2016
Institute of Human Genetics, University of Leipzig Medical Center
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

May 18, 2021
Genome-Nilou Lab
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Uncertain:3Benign:1
-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Feb 06, 2020
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 30548430) -

Aug 29, 2017
Eurofins Ntd Llc (ga)
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Intellectual disability Uncertain:1
Jan 01, 2019
Centre de Biologie Pathologie Génétique, Centre Hospitalier Universitaire de Lille
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.32
BayesDel_addAF
Benign
-0.089
T
BayesDel_noAF
Uncertain
0.10
CADD
Benign
22
DANN
Uncertain
1.0
DEOGEN2
Pathogenic
0.93
D;.
Eigen
Pathogenic
0.74
Eigen_PC
Uncertain
0.64
FATHMM_MKL
Uncertain
0.96
D
LIST_S2
Uncertain
0.87
D;D
M_CAP
Uncertain
0.27
D
MetaRNN
Benign
0.021
T;T
MetaSVM
Pathogenic
0.80
D
MutationAssessor
Pathogenic
3.3
M;.
PhyloP100
4.1
PrimateAI
Benign
0.45
T
PROVEAN
Uncertain
-2.7
D;D
REVEL
Pathogenic
0.74
Sift
Uncertain
0.0020
D;D
Sift4G
Uncertain
0.0030
D;.
Polyphen
1.0
D;.
Vest4
0.51
MVP
0.96
MPC
0.46
ClinPred
0.79
D
GERP RS
5.7
Varity_R
0.91
gMVP
0.63
Mutation Taster
=32/68
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs146381591; hg19: chr4-178359970; API